Your browser doesn't support javascript.
loading
Preclinical Evaluation of a Fluorescent Probe Targeting Receptor CDCP1 for Identification of Ovarian Cancer.
He, Yaowu; Khan, Tashbib; Kryza, Thomas; Jones, Martina L; Goh, Justin B; Lyons, Nicholas J; Pearce, Lesley A; Lee, Michael D; Gough, Madeline; Rogers, Rebecca; Davies, Claire M; Gilks, C Blake; Hodgkinson, Thomas; Lourie, Rohan; Barry, Sinead C; Perrin, Lewis C; Williams, Charlotte C; Puttick, Simon; Adams, Timothy E; Munro, Trent P; Hooper, John D; Chetty, Naven.
Afiliación
  • He Y; Mater Research Institute - The University of Queensland, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD 4102, Australia.
  • Khan T; Mater Research Institute - The University of Queensland, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD 4102, Australia.
  • Kryza T; Mater Research Institute - The University of Queensland, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD 4102, Australia.
  • Jones ML; Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, QLD 4072, Australia.
  • Goh JB; Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, QLD 4072, Australia.
  • Lyons NJ; Mater Research Institute - The University of Queensland, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD 4102, Australia.
  • Pearce LA; CSIRO Manufacturing, Parkville, VIC 3052, Australia.
  • Lee MD; CSIRO Manufacturing, Parkville, VIC 3052, Australia.
  • Gough M; Mater Research Institute - The University of Queensland, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD 4102, Australia.
  • Rogers R; Mater Research Institute - The University of Queensland, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD 4102, Australia.
  • Davies CM; Mater Health Services, South Brisbane, QLD 4101, Australia.
  • Gilks CB; Mater Research Institute - The University of Queensland, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD 4102, Australia.
  • Hodgkinson T; Mater Health Services, South Brisbane, QLD 4101, Australia.
  • Lourie R; Department of Pathology and Laboratory Medicine, Vancouver General Hospital, University of British Columbia, Vancouver, BC V6T 2B5, Canada.
  • Barry SC; Karl Storz Endoscopy, West End, QLD 4101, Australia.
  • Perrin LC; Mater Health Services, South Brisbane, QLD 4101, Australia.
  • Williams CC; Mater Health Services, South Brisbane, QLD 4101, Australia.
  • Puttick S; Mater Health Services, South Brisbane, QLD 4101, Australia.
  • Adams TE; CSIRO Manufacturing, Parkville, VIC 3052, Australia.
  • Munro TP; CSIRO Manufacturing, Parkville, VIC 3052, Australia.
  • Hooper JD; CSIRO Manufacturing, Parkville, VIC 3052, Australia.
  • Chetty N; Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, QLD 4072, Australia.
Mol Pharm ; 18(9): 3464-3474, 2021 09 06.
Article en En | MEDLINE | ID: mdl-34448393

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Moléculas de Adhesión Celular / Imagen Óptica / Colorantes Fluorescentes / Anticuerpos Monoclonales Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Mol Pharm Asunto de la revista: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Moléculas de Adhesión Celular / Imagen Óptica / Colorantes Fluorescentes / Anticuerpos Monoclonales Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Mol Pharm Asunto de la revista: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos